These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 38226560)
21. Melasma: systematic review of the systemic treatments. Zhou LL; Baibergenova A Int J Dermatol; 2017 Sep; 56(9):902-908. PubMed ID: 28239840 [TBL] [Abstract][Full Text] [Related]
22. Randomized, Double-Blinded, Split-Face Study Comparing the Efficacy and Tolerability of Two Topical Products for Melasma. Kaufman BP; Alexis AF J Drugs Dermatol; 2020 Sep; 19(9):822-827. PubMed ID: 33026755 [TBL] [Abstract][Full Text] [Related]
23. A randomized, double-blind, placebo-controlled trial of vitamin C iontophoresis in melasma. Huh CH; Seo KI; Park JY; Lim JG; Eun HC; Park KC Dermatology; 2003; 206(4):316-20. PubMed ID: 12771472 [TBL] [Abstract][Full Text] [Related]
25. Topical isoniazid as a novel treatment for melasma: A randomized, double-blind, vehicle-controlled clinical trial. Ahramiyanpour N; Mahmoudi Z; Nezhad NZ; Khazaeli P; Amiri R; Kasraee B J Cosmet Dermatol; 2024 Aug; 23(8):2636-2643. PubMed ID: 38581222 [TBL] [Abstract][Full Text] [Related]
26. Effects of melatonin on physical fatigue and other symptoms in patients with advanced cancer receiving palliative care: A double-blind placebo-controlled crossover trial. Lund Rasmussen C; Klee Olsen M; Thit Johnsen A; Petersen MA; Lindholm H; Andersen L; Villadsen B; Groenvold M; Pedersen L Cancer; 2015 Oct; 121(20):3727-36. PubMed ID: 26178160 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of fluocinolone acetonide, hydroquinone, and tretinoin cream in chinese patients with melasma: a randomized, double-blind, placebo-controlled, multicenter, parallel-group study. Gong Z; Lai W; Zhao G; Wang X; Zheng M; Li L; Yang Q; Dang Y; Liu L; Zou Y Clin Drug Investig; 2015 Jun; 35(6):385-95. PubMed ID: 25989732 [TBL] [Abstract][Full Text] [Related]
28. Comparison of therapeutic effects of conventional and liposomal form of 4% topical hydroquinone in patients with melasma. Taghavi F; Banihashemi M; Zabolinejad N; Salehi M; Jaafari MR; Marhamati H; Golnouri F; Dorri M J Cosmet Dermatol; 2019 Jun; 18(3):870-873. PubMed ID: 30105847 [TBL] [Abstract][Full Text] [Related]
29. The treatment of melasma by silymarin cream. Altaei T BMC Dermatol; 2012 Oct; 12():18. PubMed ID: 23031632 [TBL] [Abstract][Full Text] [Related]
30. Treatment of Melasma with Tranexamic Acid Essence Combined with Iontophoresis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Guo L; Liu X; Liu Q; Xie X; Jiang X Drug Des Devel Ther; 2024; 18():3659-3666. PubMed ID: 39185080 [TBL] [Abstract][Full Text] [Related]
31. Preoperative anxiolytic effect of melatonin and clonidine on postoperative pain and morphine consumption in patients undergoing abdominal hysterectomy: a double-blind, randomized, placebo-controlled study. Caumo W; Levandovski R; Hidalgo MP J Pain; 2009 Jan; 10(1):100-8. PubMed ID: 19010741 [TBL] [Abstract][Full Text] [Related]
32. Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst-blinded, randomized controlled trial with a short-term follow-up. Lajevardi V; Ghayoumi A; Abedini R; Hosseini H; Goodarzi A; Akbari Z; Hedayat K J Cosmet Dermatol; 2017 Jun; 16(2):235-242. PubMed ID: 27762489 [TBL] [Abstract][Full Text] [Related]
33. Effective Tyrosinase Inhibition by Thiamidol Results in Significant Improvement of Mild to Moderate Melasma. Arrowitz C; Schoelermann AM; Mann T; Jiang LI; Weber T; Kolbe L J Invest Dermatol; 2019 Aug; 139(8):1691-1698.e6. PubMed ID: 30825454 [TBL] [Abstract][Full Text] [Related]
34. A cream of herbal mixture to improve melasma. Zhang Q; Tu Y; Gu H; Sun D; Wu W; Man MQ; Chen H; Liu H; Ma X; He L J Cosmet Dermatol; 2019 Dec; 18(6):1721-1728. PubMed ID: 30980618 [TBL] [Abstract][Full Text] [Related]
35. The effect of melatonin on sleep quality after laparoscopic cholecystectomy: a randomized, placebo-controlled trial. Gögenur I; Kücükakin B; Bisgaard T; Kristiansen V; Hjortsø NC; Skene DJ; Rosenberg J Anesth Analg; 2009 Apr; 108(4):1152-6. PubMed ID: 19299778 [TBL] [Abstract][Full Text] [Related]
36. A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma. Chan R; Park KC; Lee MH; Lee ES; Chang SE; Leow YH; Tay YK; Legarda-Montinola F; Tsai RY; Tsai TH; Shek S; Kerrouche N; Thomas G; Verallo-Rowell V Br J Dermatol; 2008 Sep; 159(3):697-703. PubMed ID: 18616780 [TBL] [Abstract][Full Text] [Related]
37. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial. Adalatkhah H; Sadeghi-Bazargani H Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129 [TBL] [Abstract][Full Text] [Related]
38. The formulation and efficacy of topical Javedan K; Hydarpur F; Mohammadi Pour P; Najafi F; Mirzaeei S; Rahimi R; Gravandi MM; Farzaei MH J Complement Integr Med; 2022 Sep; 19(3):743-751. PubMed ID: 33964194 [TBL] [Abstract][Full Text] [Related]
39. Tranexamic acid microinjections versus tranexamic acid mesoneedling in the treatment of facial melasma: A randomized assessor-blind split-face controlled trial. Poostiyan N; Alizadeh M; Shahmoradi Z; Fatemi Naeini F J Cosmet Dermatol; 2023 Apr; 22(4):1238-1244. PubMed ID: 36606390 [TBL] [Abstract][Full Text] [Related]
40. Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment. Lozano A; Marruecos J; Rubió J; Farré N; Gómez-Millán J; Morera R; Planas I; Lanzuela M; Vázquez-Masedo MG; Cascallar L; Giralt J; Escames G; Valentí V; Grima P; Bosser R; Tarragó C; Mesía R Clin Transl Oncol; 2021 Sep; 23(9):1801-1810. PubMed ID: 33738704 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]